Introduction
Pseudomyxoma peritonei is a rare borderline malignant condition, which develops following rupture of an appendicular tumour into the peritoneal cavity. The tumour cells spread throughout the peritoneal cavity and produce mucinous material. The prevalence is estimated to be 1:1,000,000 population per year.
Standard surgical treatment involves laparotomy, multiple bowel and organ resections, cytoreductive surgery, and intraoperative heated intraperitoneal chemotherapy (HIPEC). The average surgical time in our centre is 10.5 hours.
Published reports identify a significant postoperative morbidity of approximately 66%, with the commonest complications being postoperative ileus and anastamotic leak. In light of this, total parenteral nutrition (TPN) is started postoperatively, with an average time to first enteral intake of nine days. Oral medications are replaced with an intravenous alternative until enteral feeding is established.
We present the case of a sixty-one-year-old woman with hyperthyroidism presenting for a laparotomy for pseudomyxoma peritonei, and consider treatment options for hyperthyroidism in a prolonged nil by mouth state.
Case report
The patient presented in 2008 with an abdominal mass, for which subsequent computed tomography (CT) scan revealed an ovarian mass and incidental thyroid cyst. A laparotomy, total abdominal hysterectomy and bilateral salpingooophorectomy was subsequently performed, with histology revealing pseudomyxoma peritonei, and an associated borderline mucinous ovarian tumour.
One year later the patient developed a persistent cough, profuse sweating, proximal muscle weakness, palpitations, and exopthalmos. She was diagnosed with hyperthyroidism and started on carbimazole, which gradually improved her symptomatology. A further presentation with abdominal pain, led to a repeat abdominal CT that revealed wide-spread pseudomyxoma peritonei. The patient was referred to the National Pseudomyxoma Centre at Basingstoke and North Hampshire Hospital, and was listed for a laparotomy for pseudomyxoma cytoreduction combined with HIPEC.
Advice was sought from the local endocrinologist regarding the management of the patient' s hyperthyroid status. Radioactive iodine (RAI) was recommended; however, the surgical team felt that this would delay surgery for too long, and decided to go ahead with the surgery in the time frame planned initially. Immediately prior to surgery her thyroid function tests showed a TSH of 8.17 mIU/L (0.35-4.50) and free T4 of 7 pmol/L (10-17), indicating effective treatment with carbimazole.
After uneventful induction of anaesthesia the surgeons performed a greater omentectomy, splenectomy, left and right pelvic parietal peritonectomy, left and right paracolic gutter strip, total colectomy, end ileostomy, and stripping of the left hemidiaphragm.
Cytoreductive surgery is often associated with large fluid volume shifts. This is a result of the combination of intraoperative blood loss, combined with high ongoing fluid losses secondary to a diseased peritoneal surface in association with an open abdomen. Cytoreductive surgery also involves high-power diathermy, which creates a large surface area burn intra-abdominally. In this case, the intraoperative blood loss was 1810 mL; fluid administration was guided by a LiDCOrapid © (LIDCO Ltd., London, UK) haemodynamic monitor and repeated full blood count and clotting screens. Intraoperative fluid therapy consisted of 2 L of crystalloid, 6.5 L of colloid, 2 L of 4.5% human albumin, 3 units of blood and 2 units of FFP. Operating time was nine hours, following which the patient was transferred electively to the intensive care unit while sedated and ventilated.
On admission to the intensive care unit (ICU) the patient received mandatory ventilation using a Draeger Evita (Draeger Medical UK Ltd, Hemel Hempstead, UK) ventilator to maintain normocapnia with an FiO 2 of 0.5, tidal volumes of 425 mL, a PEEP of 5 cm H 2 O and a respiratory rate of 12 breaths/min. Cardiovascular support was maintained with noradrenaline infusion at 0.2 µg/kg/min, to maintain a MAP of 65 mm Hg; sedation was maintained using propofol (100 mg/hr) and remifentanil (0.1 µg/kg/min) infusions. Aside from support of the airway, breathing and circulation, initial management priorities included monitoring and correction of coagulopathy (secondary to large volume fluid administration and major blood loss), restoration of euvolaemia and ensuring adequate analgesia to enable weaning of respiratory support.
Pertinent laboratory investigations revealed a mild hypofibrinogenaemia (1.2 g/L), a haemoglobin of 78 g/L, with normal urea and electrolytes. Arterial blood gas analysis on admission revealed a metabolic acidosis, with a base excess of -6 mmol/L, and a lactate of 1.8 mmol/L.
Over the next couple of hours treatment focused on weaning ventilation to a supportive rather than mandatory mode, the administration of 2 units of cryoprecipitate and
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1 unit of red blood cells, pain control via continued epidural infusion (8 mL/hr 0.125% bupivacaine + 2 µg/mL fentanyl) and further fluid boluses guided by clinical examination, haemodynamic parameters, and blood gas analysis. Initial fluid requirements remained high, with a further 2 L of crystalloid, 1 L of colloid and 1 L of 4.5% human albumin solution administered in the first six hours of ICU admission. This resulted in a normalisation of serum lactate values and a reduction of noradrenaline requirements from 0.2 µg/kg/min to 0.1 µg/kg/min, which at this point was felt to be required to counter sedation and epidural-induced hypotension.
Over the course of the first night, the patient' s sedation was titrated to ensure a sedation score of 2, allowing further weaning of ventilator support to CPAP by the morning of postoperative day 1. Following a period of time and clinical stability on CPAP, the patient was reviewed and felt to meet extubation criteria, namely: a good cough, obeying commands, good tidal volumes, adequate analgesia and normal blood gas parameters. The patient was extubated successfully, with satisfactory blood gas analysis obtained one hour after extubation. Total parenteral nutrition (TPN) was commenced at this point, due to the likely protracted time to oral intake. The patient was felt to be at risk of re-feeding syndrome due to the combination of weight loss, and a recently reduced dietary intake, so the initial feeding rate was reduced to 10 Kcal/kg/24hr.
Over the following four hours, the patient became increasingly tachycardic up to a rate of 125 bpm (sinus tachycardia), with associated tachypnoea, confusion and hallucinations. Clinical review revealed static noradrenaline requirements, normal arterial blood gas analysis (including normal CO 2 ), normothermia and clinical signs of dehydration. Due to the presence of many potential precipitating factors for a thyrotoxic crisis, urgent thyroid function tests were ordered, revealing a TSH of 5.24 mIU/L (0.35-4.5), a T4 of 7 pmol/L (10-17) and a T3 of 2.5 pmol/L (1-2.5). This presentation was subsequently attributed to dehydration and pain; a septic screen was sent as a precaution. These results reassured the intensive care team that the symptoms were not the result of a thyrotoxic crisis; however, a review by the endocrinology team was sought with regards to the timing of the reintroduction of oral carbimazole. It was recommended that this should happen as soon as possible, with propranolol to be used if signs of thyrotoxicosis developed before oral carbimazole could be reinstituted.
Fluid boluses and an epidural top-up led to a resolution in the tachycardia, and pain scores improving. Intra-abdominal chemotherapy was administered on a daily basis as per the usual protocol at our institution for postoperative pseudomyxoma peritonei patients.
On the third postoperative day the surgical team were happy for enteral feeding to be commenced, as surgery had resulted in a total colectomy and end-ileostomy with no anastomoses. Absorption of feed was delayed until the fifth postoperative day, this being attributed to the combination of intra abdominal chemotherapy and a postoperative ileus. Upon confirmation of adequate enteral absorption, oral carbimazole was restarted. The patient remained on the ICU for a total of six days postoperatively, mainly for vasopressor support, to counter epidural-induced hypotension. Establishment on multi-modal oral analgesics (long-acting opiate, paracetamol and tramadol) occurred following confirmation of enteral absorption, allowing removal of the epidural catheter late on day 5. This enabled weaning and cessation of the noradrenaline infusion. On the sixth postoperative day, and following a reasonable period of haemodynamic stability, the patient was discharged from the ICU. She continued to recover well, full oral intake of food and fluids followed and she was deemed fit enough to be discharged home on the 15th postoperative day.
Discussion
The patient presented us with a not uncommon scenario on the ICU, the need to continue disease-modifying medications, while needing to be strictly 'nil by mouth'. There are no easily available intravenous carbimazole-like preparations, and so we were unsure what treatment options were available. Here we provide a brief review.
Hyperthyroidism
Hyperthyroidism results from the over production of free thyroxine (T4) and tri-iodothyronine (T3). The commonest cause is Graves' disease, an autoimmune condition characterised by high levels of circulating thyroid antibodies that activate the thyroid stimulating hormone (TSH) receptor 1 resulting in a hypermetabolic state. The condition is diagnosed by measuring serum T4, T3, and TSH. Thyroid antibodies can also be measured. 2 The antithyroid drugs, carbimazole and propylthiouracil are first line treatment in the UK. Side effects occur in 3-12% of patients, 3 and the maximum remission rate is 60%. 2 For those patients who relapse, RAI or surgery are treatment options. RAI can take eighteen weeks to be effective 1 and achieves remission rates of 80-98% after one dose. 2, 3 Hypothyroidism is a common side effect, and contraindications include pregnancy, breastfeeding and severe ophthalmopathy. 1 Surgery is often the most definitive treatment. A metaanalysis of 7241 patients 4 revealed that thyroidectomy (total or subtotal) successfully treated hyperthyroidism in 92% of patients with Graves' disease, however hypothyroidism is a common sequelae. 4 Surgery is particularly effective for expectant/new mothers, patients with iodine allergy, goitre, and thyroid eye disease.
Why does hyperthyroidism present a management issue?
The most serious complication of hyperthyroidism is thyroid storm, a state of life-threatening hypermetabolism that is invariably fatal if not recognised and treated promptly. Mortality rates range from 10-75%. 3, 5, 6 Surgical operations and infections are common precipitants [6] [7] [8] [9] with many reports of thyroid crises peri-and post operatively. 6, [8] [9] [10] [11] The presentation can mimic awareness, a hypertensive crisis, or malignant hyperthermia, with thyroid storms being misdiagnosed and subsequently treated as malignant hyperthermia perioperatively. 10, 12, 13 
Case reports
Pseudomyxoma cytoreduction employs heated (41-42°C) chemotherapy (HIPEC) to the abdominal cavity following tumour resection, for thirty to ninety minutes. The surgery is prolonged (median duration of ten hours 14 ) and the fluid shifts are large. Therefore, postoperative signs of a thyroid storm could be mistaken for manifestations of the surgical insult; hypovolaemia, sepsis, pain and light sedation. The omission of anti-thyroid medications increases the risk of a relapse of hyperthyroidism and thyroid storm, especially when combined with the surgical stress and potential infective complications of pseudomyxoma surgery. 5 For these reasons, rendering the patient euthyroid preoperatively is a priority, 5,7 however, in patients requiring urgent surgery there is insufficient time for oral medication to achieve this.
In the postoperative period anti-thyroid medication needs to be continued; however, if the patient is 'nil by mouth' an alternative method of drug administration must be considered.
Treatment options in the 'nil by mouth' setting
We could not predict how long the patient would need to stay 'nil by mouth' postoperatively; therefore, to maintain a euthyroid state we had to explore other methods of administration of the anti-thyroid drugs, and treatment options should the patient develop a thyroid storm.
Prevention of thyroid hormone production
Propylthiouracil and carbimazole are both used in the UK. Propylthiouracil has the added advantage of blocking peripheral conversion of T4 to T3, although carbimazole, with a longer half life, allows an increased dosing interval, which improves compliance. 5 Carbimazole is metabolised to the active methimazole, this has a mean half-life of 3.18 hours, with effects on the inhibition of iodination of thyroid protein lasting up to twentyfour hours. 15 Measurable intrathyroidal concentrations of carbimazole have been reported twenty hours after dosing. 1 Alternative administration routes for these drugs include the intravenous or rectal routes. Propoylthiouracil, [16] [17] [18] and methimazole 19 when rectally administered, have achieved therapeutic serum levels. When combined with iodide, rectal propylthiouracil has been used for the treatment of thyroid storm. 16 Intravenous preparations of methimazole have been used in the treatment of patients with thyroid storm 20 and hyperthyroidism. 21 However, the availability of this preparation is severely limited and is not stocked in our institution' s pharmacy.
Reduction of the systemic effects of thyroid hormones
Beta blockers: These are used to treat symptomatic hyperthyroidism and thyroid storm, having antiarrhythmic properties and acting via adrenergic antagonism. Propranolol is the first choice as it prevents peripheral conversion of T4 to T3; 1,6 larger doses are needed in thyrotoxic patients. 5, 22 The use of esmolol (500 µg/kg IV) for treatment of thyroid storm 5, 11 has been reported. It has a shorter onset time and duration of action, and is more cardio-selective than propranolol. Glucocorticoids: Intravenous hydrocortisone, or dexamethasone block peripheral conversion of T4 to T3. 6, 10 Both have been used in the treatment of carbimazole-resistant hyperthyroidism prior to RAI treatment. 23 Plasmapheresis: Plasmapheresis has been reported to treat thyrotoxic crises not responding to 24-48 hours of medical therapy. It was also shown to reduce serum thyroxine levels in an animal model. 24 Supportive measures: Ideally these patients should be managed on the ICU. Invasive haemodynamic monitoring may be required because of the risk of cardiac arrhythmias, congestive cardiac failure and large fluid shifts which occur as part of the syndrome.
Temperature reduction reduces the metabolic demands and also the percentage of free T4. 6
Alternative management
One management option not considered was to perform a thyroidectomy on our patient while in theatre for the pseudomyxoma cytoreduction (before or after this primary operation).
This suggestion followed a personal communication with a head and neck surgeon, experienced in performing thyroidectomy at the time of another primary operation. Our patient had thyroid eye disease and a palpable goitre, both indications for thyroid surgery. Thyroidectomy would have eliminated the concerns surrounding administration of anti-thyroid medications, reduced the risk of a thyroid storm, and provided definitive management. Postoperative hypothyroidism could have been treated with IV thyroxine or triiodothyronine. This would have made the management of the patient on the ICU postoperatively less complicated.
There are limited numbers of case reports of simultaneous operations, involving either cardiac surgery, [25] [26] [27] [28] or abdominal operations. 29 While the evidence is limited, we feel it is worth considering, and avoids the necessity for a second operation.
Summary
The postoperative management of patients with hyperthyroidism may be complex if they are unable to take oral medications. In this cohort, concurrent thyroidectomy could be considered as a treatment option.
A limited number of case reports describe alternative routes of administration of anti-thyroid medications. These alternatives should be considered if prolonged oral administration is unavailable. Careful planning will be required as formulations are not widely available.
Management of thyroid storm with conventional medical management should be instituted at the earliest possible stage prior to the laboratory confirmation of hyperthyroidism/thyroid storm.
